Effects of thyrotrophin, thyroid hormones and thyroid antibodies on metabolic parameters in a euthyroid population with obesity

Authors:

Abstract
To investigate whether thyroid function in the euthyroid range, and thyroid autoimmunity status would affect metabolic measures in individuals with obesity. Cross-sectional We retrospectively evaluated 5300 consecutive obese (BMI ≥ 30 kg/m2) subjects attending the Obesity Outpatient Clinic. Subjects with overt or subclinical thyroid disease, diabetes mellitus, chronic disease or using any medication were excluded. After exclusion, 1275 euthyroid [TSH values > 0.4 and < 4.5 μIU/mL, free triiodothyronine (FT3), free thyroxine (FT4) in the normal reference range] obese subjects (aged 18–65 years) were eligible for the study. The physical and biochemical records of the subjects at first admission to the obesity outpatient clinic were examined. Eighty three percent (n = 1063) of the study population were women. Anti-thyroid peroxidase (anti-TPO) positivity was 14% and anti-thyroglobulin (anti-TG) positivity was 15%. TSH was 1.8 μIU/mL (1.3‒2.4) in antibody negative subjects and 2.1 μIU/mL (1.4‒2.9) in antibody positive subjects. Neither TSH nor thyroid antibody positivity was associated with insülin resistance (IR) and atherogenic dyslipidemia after adjustment for confounders. FT3 was positively associated with IR (P < 0.001) and atherogenic dyslipidemia (P = 0.03); however, this association lost its significance after adjustment for age, gender and BMI. FT4 was negatively associated with IR and this association remained even after adjustment for confounders (P < 0.001). TSH and thyroid antibody positivity were not related with metabolic measures. Low normal FT4 had an inverse association with HOMA-IR even after adjustment for confounders.

This publication has 32 references indexed in Scilit: